Suppr超能文献

公共政策是否应该设法控制医疗保健支出的增长?

Should public policy seek to control the growth of health care spending?

作者信息

Aaron Henry J

机构信息

Brookings Institution, Washington, DC, USA.

出版信息

Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-28-36. doi: 10.1377/hlthaff.w3.28.

Abstract

Debate about whether to restrain health care spending is intensifying. Much of the debate revolves around efficient research allocation. The possible impact of cost control on the advance of medical technology merits more attention. Public and private efforts to slow growth of health spending have not enjoyed much success. Most recently, managed care failed because administrators lacked political legitimacy. Politically established budget limits can hold down spending, but the United States seems unwilling to adopt them; even if it were, the technology to administer them rationally does not exist. In this situation, efforts to hold down cost growth carry grave risks.

摘要

关于是否抑制医疗保健支出的争论正在加剧。大部分争论都围绕着有效的研究资源分配。成本控制对医疗技术进步的可能影响值得更多关注。公共和私人部门为减缓医疗支出增长所做的努力成效不大。最近,管理式医疗失败了,因为管理人员缺乏政治合法性。政治上设定的预算限制可以抑制支出,但美国似乎不愿意采用;即便采用,合理管理这些限制的技术也不存在。在这种情况下,抑制成本增长的努力存在巨大风险。

相似文献

1
Should public policy seek to control the growth of health care spending?公共政策是否应该设法控制医疗保健支出的增长?
Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-28-36. doi: 10.1377/hlthaff.w3.28.
6
8
Economics and urban health.经济学与城市健康。
J Urban Health. 1998 Jun;75(2):281-93. doi: 10.1007/BF02345097.
9
Where does the US experience of managed care currently stand?美国管理式医疗的现状如何?
Int J Health Plann Manage. 2005 Apr-Jun;20(2):137-57. doi: 10.1002/hpm.803.
10
National health expenditures, 1998.1998年国家卫生支出
Health Care Financ Rev. 1999 Winter;21(2):165-210.

引用本文的文献

1
The increasingly complex fourth hurdle for pharmaceuticals.制药行业日益复杂的第四道难关。
Pharmacoeconomics. 2007;25(9):727-34. doi: 10.2165/00019053-200725090-00002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验